AllerGenis
PrivateLast Round
Crowdfunding
Apr 24, 2023
Est. Valuation
$40M
Company Overview
AllerGenis is a biotechnology company that provides data-driven precision diagnostic services for food allergies.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AllerGenis Comparables
Compare AllerGenis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spiriplex, Inc. | 80% | |
| ATANIS Biotech AG | 78% | |
| MacroArray Diagnostics GmbH | 77% | |
AllerGenis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Apr 24, 2023 |
Key People
Founding team and executive leadership
AllerGenis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartEngine Crowdfunding | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2025
Monthly visitors grew 45% MoM, reaching 1K.
- Oct 29, 2024
Monthly visitors grew 291% MoM, reaching 2K.
AllerGenis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AllerGenis's valuation, stock price, and market status.